Squarepoint Ops LLC Eli Lilly & CO Call Options Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $36.5 Million - $45.4 Million	47,300 Added 175.84%	74,200 $65.7 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $50.3 Million - $63.1 Million	-69,400 Reduced 72.07%	26,900 $24.4 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $3.73 Million - $4.99 Million	6,300 Added 7.0%	96,300 $74.9 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $28.1 Million - $33.1 Million	53,500 Added 146.58%	90,000 $52.5 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $12.4 Million - $16.6 Million	35,300 Added 2941.67%	36,500 $17.1 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.74 Million - $2.04 Million	-5,600 Reduced 82.35%	1,200 $412,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $32.7 Million - $38.1 Million	-101,600 Reduced 93.73%	6,800 $2.49 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $27.2 Million - $31 Million	91,800 Added 553.01%	108,400 $35.1 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.98 Million - $2.32 Million	7,100 Added 74.74%	16,600 $5.38 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $9.76 Million - $12.1 Million	-41,600 Reduced 81.41%	9,500 $2.72 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $134,910 - $167,424	-600 Reduced 1.16%	51,100 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $110,800 - $136,355	500 Added 0.98%	51,700 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $8.52 Million - $11 Million	47,200 Added 1180.0%	51,200 $11.8 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $443,664 - $574,344	2,700 Added 207.69%	4,000 $747,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $65,230 - $86,315	-500 Reduced 27.78%	1,300 $219,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $73,110 - $84,565	500 Added 38.46%	1,800 $266,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $177,345 - $213,434	1,300 New	1,300 $213,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $488,105 - $604,135	-4,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $224,532 - $278,103	2,100 Added 105.0%	4,100 $539,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $213,580 - $232,320	2,000 New	2,000 $224,000

Others Institutions Holding LLY

# of Institutions

4,016

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$59 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.7 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$41.1 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27.1 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account